Impact of ureteroscopy on nephroureterectomy and standards of care compliance in upper tract urothelial carcinoma: the <scp>BAUS UK I‐DUNC</scp> audit
Our audit showed that d-URS is associated with significant treatment delays, increased rates of metachronous bladder cancer recurrence, and higher surgical positive margin rates in patients with ≥pT2 disease. Compliance with MMC therapy and adjuvant chemotherapy was low. This national audit highlights the need for risk-stratified diagnostic pathways, multidisciplinary expertise, and establishment of quality performance indicators to improve care and outcomes in UTUC management in the UK.
Authors
- Jonathan Aning (ORCID: https://orcid.org/0000-0001-6189-4720)
- Robert M. Geraghty (ORCID: https://orcid.org/0000-0002-9128-5173)
- James Armitage (ORCID: https://orcid.org/0000-0003-1379-0964)
- Joe Philip (ORCID: https://orcid.org/0000-0003-1330-8883)
- Robert C. Calvert
- Thomas J. Walton (ORCID: https://orcid.org/0000-0001-6966-7522)
- Alexander Laird (ORCID: https://orcid.org/0000-0002-7296-025X)
- Bhavan Prasad (ORCID: https://orcid.org/0000-0002-6323-7246)
- Vishwanath Hanchanale
Institutions
- Nottingham University Hospitals NHS Trust (GB)
- University of Liverpool (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- Western General Hospital (GB)
- Southmead Hospital (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Freeman Hospital (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Edinburgh Cancer Research (GB)
- University of Bristol (GB)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1111/bju.70013
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00